Loading
  • 21 Aug, 2019

  • By, Wikipedia

California University Of Science And Medicine

The California University of Science and Medicine (CUSM) is a private accredited medical school located in Colton, California/San Bernardino, San Bernardino County, United States. CUSM received preliminary LCME accreditation in February 2018, and enrolled students for classes conferring an M.D. degree beginning July 2018. The new CUSM campus, completed in 2020, has two lecture halls, nine college rooms, 15 clinical skills rooms and three labs. More than 2,400 students applied to CUSM's inaugural class, with 64 students enrolling in the class of 2022. In 2019, more than 5,300 students applied to CUSM, with 98 students enrolling in the class of 2023. In 2020, more than 5,300 students applied to CUSM, with 130 students enrolling in the class of 2024. The average GPA of accepted students is 3.6, with an average MCAT score of 513.

The California University of Science and Medicine currently is affiliated with Arrowhead Regional Medical Center as the primary teaching hospital. The majority of the students in the class of 2022 (80%), class of 2023 (80%), and class of 2024 (98%) comes from California.

See also

References

  1. ^ "Message from the Dean". California University of Science and Medicine. Retrieved 24 Feb 2018.
  2. ^ "Accredited MD Programs in the United States". Liaison Committee on Medical Education. Retrieved 14 May 2018.
  3. ^ "California University of Science and Medicine". SmithGroup.
  4. ^ Whitehead, Brian (26 June 2018). "New Inland Empire medical school to welcome inaugural class in July". San Bernardino Sun. Retrieved 28 August 2020.
  5. ^ "Class Profile | CUSM". www.cusm.org.
  6. ^ Steinberg, Jim (8 March 2017). "San Bernardino County awards new Colton medical school a $10 million contract". San Bernardino Sun. Retrieved 14 May 2018.
  7. ^ "State's newest medical school, founded by Dr. Prem Reddy, sees 98 students take Hippocratic Oath at White Coat Ceremony". Victorville Daily Press. 25 July 2019. Retrieved 8 September 2020.